ULK1, AS A KEY DETERMINANT OF RENAL TUBULE RECOVERY IN CHRONIC KIDNEY DISEASE REVEALED BY SINGLE-CELL ANALYSIS

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
 
ULK1, AS A KEY DETERMINANT OF RENAL TUBULE RECOVERY IN CHRONIC KIDNEY DISEASE REVEALED BY SINGLE-CELL ANALYSIS

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Tomohiro
Tsuboya
Tomohiro Tsuboya tsuboya.tomohiro@tmd.ac.jp Institute of Science Tokyo Nephrology Tokyo Japan *
Hiroaki Kikuchi hkikuchi.kid@tmd.ac.jp Institute of Science Tokyo Nephrology Tokyo Japan -
Hu Jinming h15831629789@outlook.com Institute of Science Tokyo Nephrology Tokyo Japan -
Mari Sugimoto sugimoto.peri@tmd.ac.jp Institute of Science Tokyo Nephrology Tokyo Japan -
Takefumi Suzuki tsuzuki.kid@tmd.ac.jp Institute of Science Tokyo Nephrology Tokyo Japan -
Yohei Arai yarai.kid@tmd.ac.jp Institute of Science Tokyo Nephrology Tokyo Japan -
Tamami Fujiki tfujiki.kid@tmd.ac.jp Institute of Science Tokyo Nephrology Tokyo Japan -
Yutaro Mori y-mori.kid@tmd.ac.jp Institute of Science Tokyo Nephrology Tokyo Japan -
Fumiaki Ando fandoh.kidc@tmd.ac.jp Institute of Science Tokyo Nephrology Tokyo Japan -
Takayasu Mori tmori.kid@tmd.ac.jp Institute of Science Tokyo Nephrology Tokyo Japan -
Koichiro Susa ksusa.kid@tmd.ac.jp Institute of Science Tokyo Nephrology Tokyo Japan -
Shintaro Mandai smandai.kid@tmd.ac.jp Institute of Science Tokyo Nephrology Tokyo Japan -
Shinichi Uchida suchida.kid@tmd.ac.jp Institute of Science Tokyo Nephrology Tokyo Japan -
Eisei Sohara esohara.kid@tmd.ac.jp Institute of Science Tokyo Nephrology Tokyo Japan -
-

Chronic kidney disease (CKD) is characterized by progressive kidney function decline, in which irreversible changes in tubular epithelial cells play a central role. We recently reported that dysfunction of AMP-activated protein kinase (AMPK) and associated lipid metabolism impairment are critical in CKD pathogenesis. However, it remains unclear which nephron segments are involved and what mechanisms are responsible for epithelial cell injury and repair driven by these pathways.

To evaluate the transition from tubular epithelial injury to CKD, we employed a folic acid nephropathy model. C57BL/6 mice were administered folic acid, and kidney function and pathology were assessed over time. Kidneys were harvested and analyzed alongside healthy controls using bulk renal RNA sequencing and single-cell RNA sequencing (scRNA-seq) to perform comprehensive single-cell transcriptome analysis. Clustering and pseudotime analyses were conducted to comprehensively elucidate the signaling pathways responsible for the progression from cellular injury to repair or failure.

Kidney function declined rapidly within two weeks after folic acid administration and partially recovered thereafter. By four weeks, injury had stabilized and CKD pathology was established. Bulk RNA-seq at four weeks revealed increased interferon (IFN) signaling and decreased LKB1-AMPK signaling. scRNA-seq identified a novel cell cluster exclusively present in CKD kidneys, exhibiting features of proximal tubules while expressing genes typical of thick ascending loop of Henle (TAL) and distal tubule segments (e.g., Umod, Slc12a3, Slc12a1). This cluster likely represents “naive” tubular epithelial cells that have dedifferentiated post-injury. Pseudotime analysis focusing on this cluster and proximal tubule cells demonstrated that AMPK signaling, particularly Unc-51-like kinase (ULK1) -AMPKγ signaling involved in energy sensing, is critical for determining the fate of dedifferentiated epithelial cells.

Following CKD-inducing injury, proximal tubular cells dedifferentiate into naive tubular cells exhibiting gene expression patterns reminiscent of TAL and distal tubules. The repair process of these naive tubular cells is regulated by IFN signaling and ULK1-AMPK signaling within tubular epithelium, highlighting potential therapeutic targets for enhancing tubular repair in CKD.

Kewords